Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

ANDA Changes May Require Paragraph IV Recertification, New 30-Month Stay

Executive Summary

Brand litigants are beginning to argue that post-Markman application tweaks are in essence new applications eligible for new 30-month stays.

You may also be interested in...



FDA’s ‘Monster’ Proposed Rule Targets Patent Use Codes, Paragraph IV Certification

Industry has 90 days to comment on FDA’s current handling of generic challenges to brand protections.

Baxter Seeks Unusual Second 30-Month Stay On Generic Version Of Its Anesthetic Suprane

A redesign of the proposed generic and changes to the Paragraph IV certification could give the brand an additional six-month hold on approval of the ANDA.

Merger Enforcement: FTC And Justice Department Casting Wide Net In Considering Changes

Agencies seek public comment on how they can modernize merger guidelines to enforce antitrust laws. List of questions, including what types of evidence show that a merger could reduce competition, indicate pharma and other mergers will face greater scrutiny.

Topics

Related Companies

UsernamePublicRestriction

Register

PS054859

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel